Literature DB >> 35132239

Low-dose rituximab can go even lower.

Robert Phillips1.   

Abstract

Entities:  

Year:  2022        PMID： 35132239     DOI： 10.1038/s41584-022-00757-9

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Drug levels, anti-drug antibodies and B-cell counts were not predictive of response in rheumatoid arthritis patients on (ultra-)low-dose rituximab.

Authors:  Maike H M Wientjes; Titia M G Gijzen; Nathan den Broeder; Karien Bloem; Annick de Vries; Bart J F van den Bemt; Alfons A den Broeder; Lise M Verhoef
Journal:  Rheumatology (Oxford)       Date:  2022-10-06       Impact factor: 7.046
  1 in total
  1 in total

1.  Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model.

Authors:  Kevin Hollevoet; Debby Thomas; Griet Compernolle; Giles Vermeire; Elien De Smidt; Stéphanie De Vleeschauwer; Trevor R F Smith; Paul D Fisher; Maarten Dewilde; Nick Geukens; Paul Declerck
Journal:  Front Oncol       Date:  2022-10-03       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.